Case Report: Delayed hemobilia caused by hepatic artery pseudoaneurysm with arterio-biliary fistula after liver transplantation
- 1Yunnan Institute of Digestive Disease, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China
- 2Kunming Medical University, Kunming, Yunnan, China
Abstract
Background: Hepatic artery pseudoaneurysm (HAP) is a rare but life-threatening complication following liver transplantation (LT). The formation of an arterio-biliary fistula leading to hemobilia is exceptionally uncommon, particularly when manifesting several months post-transplantation. Diagnosis and therapeutic management remain highly challenging because achieving definitive hemostasis often conflicts with the critical need to preserve graft arterial perfusion.
Case presentation: A 23-year-old male presented with recurrent hematemesis, hematochezia, and right upper quadrant pain 4 months after undergoing orthotopic LT for end-stage alcohol-related cirrhosis. While initial endoscopy pointed toward a duodenal bulb ulcer, a repeat endoscopic evaluation revealed fresh blood actively emerging from the major duodenal papilla, raising strong suspicion for hemobilia. Subsequent digital subtraction angiography (DSA) demonstrated a post-transplant HAP arising from the hilar hepatic arterial segment, communicating directly with the common bile duct, confirming an arterio-biliary fistula. Two sessions of transcatheter coil embolization achieved only temporary hemostasis. Following an early recurrence of bleeding, the patient underwent emergency surgery. The lesion was identified on the left hepatic artery near the porta hepatis. The surgical intervention included pseudoaneurysm resection, end-to-end hepatic artery reconstruction, and a Roux-en-Y biliary-enteric anastomosis. Despite an initially stable early postoperative course, the patient suffered a sudden circulatory collapse on postoperative day 6 and died despite aggressive resuscitation.
Conclusions: Hemobilia should be considered in liver transplant recipients with recurrent or unexplained gastrointestinal bleeding, particularly when blood is observed emerging from the major duodenal papilla. DSA should be performed promptly when clinical suspicion remains high, even if post-embolization CTA is inconclusive. Recurrent bleeding after embolization may indicate persistent fistulous communication and should prompt early multidisciplinary reassessment of definitive treatment options.
Related
- Intraportal Rupture of a Hepatic Hydatid Cyst Complicated by Arterioportal Fistula and Hepatic Artery Pseudoaneurysm.
- Delayed Renal Artery Stump Pseudoaneurysm and Arteriovenous Fistula Following Nephrectomy Complicated by Pulmonary Coil Migration: Successful Laparoscopic Management
- Transhepatic chest tube malposition complicated by delayed hepatic hemorrhage following tube removal: A case report and literature review
- Early postoperative galectin-3 for risk stratification of delayed graft function after kidney transplantation
- Impact of Hepatic Artery Diameter on Immediate Postoperative Graft Function and Hemodynamic Profiles in Living-Donor Liver Transplantation: A Retrospective Cohort Study
BibTeX
@article{ren2026case,
title = {{Case Report: Delayed hemobilia caused by hepatic artery pseudoaneurysm with arterio-biliary fistula after liver transplantation}},
author = {Qianlang Ren and Xianmei Wang and Dejia Xiong and Yanxin Zhao and Guoqing Wang and Junyan Lv and Lanqing Ma},
journal = {Frontiers in Medicine},
year = {2026},
month = oct,
doi = {10.3389/fmed.2026.1940000},
url = {https://doi.org/10.3389/fmed.2026.1940000},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Case Report: Delayed hemobilia caused by hepatic artery pseudoaneurysm with arterio-biliary fistula after liver transplantation
AU - Qianlang Ren
AU - Xianmei Wang
AU - Dejia Xiong
AU - Yanxin Zhao
AU - Guoqing Wang
AU - Junyan Lv
AU - Lanqing Ma
PY - 2026
DA - 2026/10/13
JO - Frontiers in Medicine
DO - 10.3389/fmed.2026.1940000
UR - https://doi.org/10.3389/fmed.2026.1940000
AB - Background: Hepatic artery pseudoaneurysm (HAP) is a rare but life-threatening complication following liver transplantation (LT). The formation of an arterio-biliary fistula leading to hemobilia is exceptionally uncommon, particularly when manifesting several months post-transplantation. Diagnosis and therapeutic management remain highly challenging because achieving definitive hemostasis often conflicts with the critical need to preserve graft arterial perfusion. Case presentation: A 23-year-old male presented with recurrent hematemesis, hematochezia, and right upper quadrant pain 4 months after undergoing orthotopic LT for end-stage alcohol-related cirrhosis. While initial endoscopy pointed toward a duodenal bulb ulcer, a repeat endoscopic evaluation revealed fresh blood actively emerging from the major duodenal papilla, raising strong suspicion for hemobilia. Subsequent digital subtraction angiography (DSA) demonstrated a post-transplant HAP arising from the hilar hepatic arterial segment, communicating directly with the common bile duct, confirming an arterio-biliary fistula. Two sessions of transcatheter coil embolization achieved only temporary hemostasis. Following an early recurrence of bleeding, the patient underwent emergency surgery. The lesion was identified on the left hepatic artery near the porta hepatis. The surgical intervention included pseudoaneurysm resection, end-to-end hepatic artery reconstruction, and a Roux-en-Y biliary-enteric anastomosis. Despite an initially stable early postoperative course, the patient suffered a sudden circulatory collapse on postoperative day 6 and died despite aggressive resuscitation. Conclusions: Hemobilia should be considered in liver transplant recipients with recurrent or unexplained gastrointestinal bleeding, particularly when blood is observed emerging from the major duodenal papilla. DSA should be performed promptly when clinical suspicion remains high, even if post-embolization CTA is inconclusive. Recurrent bleeding after embolization may indicate persistent fistulous communication and should prompt early multidisciplinary reassessment of definitive treatment options.
SN - 2296-858X
ER -